SE
Seer
SEER·NASDAQRedwood City CAFounded 2017150 employees
Small CapbiotechPublicOncology
Platform: Proteograph Prot
Market Cap
$0.3B
All Drugs
2
Clinical Trials
5
Failed / Terminated
0
FDA Approved
0
Stock Price & Catalysts (SEER)
Loading SEER stock data...
Drug Pipeline (2 programs)
| Drug Name | Code | Phase | Trials | Modality | Target | MOA | Indications |
|---|---|---|---|---|---|---|---|
| Nidatenlimab | SEE-9976 | Phase 1 | 2 | AuroraA | NASH | ||
| Sovalemzoparlimab | SEE-5445 | Phase 3 | 3 | GPRC5D | MSMigraine |
SEC Filings & Financial Documents
Insider Trading Activity
Fetching insider trading data from SEC EDGAR...
Catalyst Events (5)